Sarah Bhagat

Sarah Bhagat is a Biotech Investor based in Menlo Park, California, with a background in neuroscience and extensive experience in various biotech investment firms. She has successfully invested in companies like Atsena Therapeutics and Inozyme at early stages, demonstrating a strong track record in identifying promising ventures and contributing to their growth. With a PhD from Yale University and experience as a General Partner at Sofinnova Investments, Sarah Bhagat has a deep understanding of the biotech industry and a proven ability to strategically invest in companies within sectors like Pharmaceuticals, Digital Health, and Consumer Health.